The invention provides tetrahydro[1,8]naphthyridine and related compounds, pharmaceutical compositions, methods of promoting ROR activity, increasing the amount of IL-17 in a subject, and treating cancer using such tetrahydro[1,8]naphthyridine and related compounds.
本发明提供了四氢[1,8]
萘啶及相关化合物、药物组合物、促进 ROR 活性的方法、增加受试者体内 IL-17 含量的方法以及使用此类四氢[1,8]
萘啶及相关化合物治疗癌症的方法。